Author: Serena H. Chen; M. Todd Young; John Gounley; Christopher Stanley; Debsindhu Bhowmik
Title: Distinct Structural Flexibility within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets Document date: 2020_4_18
ID: klb8oe9q_3
Snippet: understanding of the molecular pathways of SARS-CoV-2 and constituent structures. The structural biology community has made rapid progress towards this goal by experimentally determining several SARS-CoV-2 proteins, including the spike (S) [3] - [6] , nucleocapsid (N) [7] , and main protease (M pro ) [8] . The S protein is particularly important since it resides on the viral envelope and is responsible for host cell entry by engaging angiotensin-.....
Document: understanding of the molecular pathways of SARS-CoV-2 and constituent structures. The structural biology community has made rapid progress towards this goal by experimentally determining several SARS-CoV-2 proteins, including the spike (S) [3] - [6] , nucleocapsid (N) [7] , and main protease (M pro ) [8] . The S protein is particularly important since it resides on the viral envelope and is responsible for host cell entry by engaging angiotensin-converting enzyme 2 (ACE2) receptors [2] , [9] , [10] . Recent experimental structures of the SARS-CoV-2 S protein receptor binding domain (RBD) in complex with ACE2 provide detailed interface information [4] , [6] ; targeting this interface represents an active area of research for therapeutic development [11] . However, there may exist potential targets on the S protein besides the RBD domain.
Search related documents:
Co phrase search for related documents- active area and main protease: 1
- active area and potential target: 1, 2
- active area and rapid progress: 1
- angiotensin convert and host cell: 1
- binding domain and experimental structure: 1, 2, 3, 4, 5, 6
- binding domain and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- binding domain and host cell entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- binding domain and interface information: 1, 2, 3
- binding domain and interface target: 1, 2, 3, 4, 5
- binding domain and main protease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- binding domain and molecular pathway: 1
- binding domain and potential target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- binding domain and rapid progress: 1, 2
- binding domain and RBD domain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- biology community and experimental structure: 1, 2
- biology community and main protease: 1
- biology community and potential target: 1
- constituent SARS and main protease: 1
- constituent SARS and potential target: 1
Co phrase search for related documents, hyperlinks ordered by date